Amy Elazzouzi Sells Shares of Aura Biosciences, Inc.
2025-10-29SEC Filing 4 (0001193125-25-256620)
On October 29, 2025, Amy Elazzouzi, Senior Vice President of Finance at Aura Biosciences, Inc., sold 896 shares of common stock at a price of $6.35 per share. This transaction was conducted to cover tax withholding obligations related to the vesting of restricted stock units and was automatic, not at the discretion of Elazzouzi. Following the transaction, Elazzouzi owns 85,662 shares of Aura Biosciences, Inc. common stock. The filing, submitted as a Form 4, provides transparency into the financial activities of corporate officers and ensures compliance with SEC regulations.
Tickers mentioned in this filing:AURA
The link to the original SEC document:https://www.sec.gov/Archives/edgar/data/1501796/0001193125-25-256620.txt